Talampanel, a Novel Noncompetitive AMPA Antagonist, is Neuroprotective after Traumatic Brain Injury in Rats
- 1 October 2001
- journal article
- Published by Mary Ann Liebert Inc in Journal of Neurotrauma
- Vol. 18 (10) , 1031-1038
- https://doi.org/10.1089/08977150152693728
Abstract
Talampanel [(R)-7-acetyl-5-(4-aminophenyl)-8,9-dihydro-8-methyl-7H-1,3-dioxolo[4,5-h][2,3] benzodiazepine] is an orally active noncompetitive antagonist of the AMPA subtype of glutamate excitatory amino acid receptors. The purpose of this study was to determine whether treatment with talampanel would protect in a rat model of traumatic brain injury (TBI). Twenty-four hours prior to TBI, a fluid-percussion interface was positioned parasagittally over the right cerebral cortex. On the following day, fasted rats were anesthetized with 3% halothane, 70% nitrous oxide, and a balance of oxygen; mechanically ventilated and physiologically regulated; and subjected to right parieto-occipital parasagittal fluid-percussion injury (1.5-2.0 atm). The agent (talampanel, bolus infusion of 4 mg/kg followed by infusion of 4 mg/kg/h over 72 h) or vehicle was administered i.v. starting at either 30 min or 3 h after trauma. Seven days after TBI, brains were perfusion-fixed, coronal sections at various levels were digitized, and contusion areas were measured. Treatment with talampanel, when instituted 30 min after trauma, significantly reduced total contusion area compared to vehicle-treated rats (0.54 +/- 0.25 vs. 1.79 +/- 0.42 mm2, respectively). When talampanel treatment was begun at 3 h, the neuroprotective effect of the drug was lost. In addition, treatment with talampanel starting at 30 min significantly attenuated neuronal damage in all three subsectors of the hippocampal CA1 sector compared to vehicle-treated rats (normal-neuron counts, right (ipsilateral) medial CA1: 80.3 +/- 2.0 [talampanel] vs. 66.3 +/- 2.1 [vehicle] (mean +/- SEM); middle CA1: 71.5 +/- 2.0 vs. 60.3 +/- 2.2; lateral CA1: 74.5 +/- 3.0 vs. 63.0 +/- 3.2, respectively). By contrast, when talampanel treatment was begun at 3 h, normal pyramidal-neuron counts were almost identical in both groups. Our findings document that talampanel therapy instituted 30 min after trauma significantly reduces histological damage.Keywords
This publication has 22 references indexed in Scilit:
- Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepamEuropean Journal of Pharmacology, 1999
- Posttreatment With High-Dose Albumin Reduces Histopathological Damage and Improves Neurological Deficit Following Fluid Percussion Brain Injury in RatsJournal of Neurotrauma, 1999
- Clinical Neuro-Protection Trials in Severe Traumatic Brain Injury: Lessons from Previous StudiesJournal of Neurotrauma, 1997
- Glutamate Release and Free Radical Production Following Brain Injury: Effects of Posttraumatic HypothermiaJournal of Neurochemistry, 1995
- Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the ratActa Neuropathologica, 1994
- Pharmacological strategies in CNS traumaTrends in Pharmacological Sciences, 1992
- Identification of a Site in Glutamate Receptor Subunits That Controls Calcium PermeabilityScience, 1991
- Ca2 + Permeability of KA-AMPA—Gated Glutamate Receptor Channels Depends on Subunit CompositionScience, 1991
- The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult ratsJournal of Neuroscience, 1991
- Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones.The Journal of Physiology, 1990